株式会社ゼウレカ

  • HOME
  • COMPANY
    • ABOUT US
    • OUR TEAM
  • SERVICE
    • Computational Drug Discovery Solution​​
    • Tokyo-1
  • NEWS
  • BLOG
  • CAREER

  • February 18, 2026

    Our CTO Makiguchi to Speak at a Seminar Hosted by the Japan Pharmaceutical Manufacturers Association (JPMA)

    READ MORE

  • February 16, 2026

    Xeureka Held the Third Executive Board Meeting of Tokyo-1

    READ MORE

  • December 16, 2025

    Xeureka Launches Joint Research Collaboration with the Lokey Laboratory at UC Santa Cruz on the Membrane Permeability of Cyclic Peptides

    READ MORE

  • December 11, 2025

    Xeureka and UBE Announce Joint Research Agreement on Small-Molecule Drug Discovery in the Oncology Field

    READ MORE

  • November 28, 2025

    【Event Report】Sponsored Session at the CBI Annual Meeting 2025: GPU × AI-Powered Drug Discovery R&D — Sharing Knowledge and Growing the Tokyo-1 Community

    READ MORE

  • November 11, 2025

    Xeureka Signs Contract with RealizeEdge Partners for the Discovery of Candidate Compounds for Targeted Protein Degraders

    READ MORE

  • November 07, 2025

    Our General Manager of Science & Technology, Ryushi Seo, will present at the Pioneering Drug Discovery Technology/Art for the Future session of the 42nd Medicinal Chemistry Symposium

    READ MORE

  • October 17, 2025

    Sponsored Session at the CBI Annual Meeting 2025: GPU × AI-Powered Drug Discovery R&D — Sharing Knowledge and Growing the Tokyo-1 Community

    READ MORE

  • October 03, 2025

    Tokyo-1 Drug Discovery Hackathon 2025 Event Report

    READ MORE

  • 1
  • 2
  • 3
INNOVATOR OF DRUG DISCOVERY THROUGH CONVERGENCE OF DRY & WET

COMPANY

  • About us
  • Our Team

SERVICE

  • Computational Drug Discovery Solution
  • Tokyo-1

CAREER

NEWS

BLOG

CONTACT

Xeureka Inc.
Toranomon 30 Mori Building 9F
3-2-2 Toranomon
Minato-ku, Tokyo 105-0001, Japan

© Xeureka Inc.

  • HOME
  • ABOUT US
  • OUR TEAM
  • SERVICE
  • CAREER
  • NEWS
  • BLOG
  • EN
  • JP